Tarhini, A. (2013). Immune-Mediated Adverse Events Associated with Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management. Hindawi Publishing Corporation.
Chicago Style CitationTarhini, Ahmad. Immune-Mediated Adverse Events Associated With Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management. Hindawi Publishing Corporation, 2013.
Cita MLATarhini, Ahmad. Immune-Mediated Adverse Events Associated With Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management. Hindawi Publishing Corporation, 2013.
Atenció: Aquestes cites poden no estar 100% correctes.